|
CI23-10022
|
Smart dendritic contrast agent for accurate stroke diagnosis by computed tomography
|
Victoria Leiro
|
i3S – Instituto de Investigação e Inovação em Saúde da Universidade do Porto - Associação
|
Individual
|
N/A
|
STAGE
1
|
Diagnostics
|
49,996(*)
|
|
CI23-10074
|
Pre-clinical development of a DNA vaccine to elicit immunity against K. pneumoniae virulence factors
|
Mireia López
|
Universitat de Girona
|
Individual
|
N/A
|
STAGE
1
|
Therapeutics
|
50,000
|
|
CI23-10079
|
Overcoming resistance to virotherapy for pediatric brain tumors
|
Marta Alonso
|
Fundación para la Investigación Médica Aplicada (FIMA/CIMA)
|
Individual
|
N/A
|
STAGE
1
|
Therapeutics
|
50,000
|
|
CI23-10134
|
Nano-coatings for prosthetics based on microbial phenazines conjugated with silver nanostars
|
Pedro Soares
|
Instituto de Medicina Molecular
|
Individual
|
N/A
|
STAGE
1
|
Medical Devices
|
50,000
|
|
CI23-10157
|
Revolutionizing Electronic Skin: Biobatteries Powered
by Collagen-based biomaterials
|
Ana Pina
|
Universidade Nova de Lisboa
|
Consortium
|
Materials Research
Center (CENIMAT) of the Associated Laboratory i3N, Institute of Nanostructures, Nanomodeling and Nanofabrication (I3N), Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa (FCT-NOVA)
UCIBIO - Applied Molecular Biosciences
Unit, Associate Laboratory
i4HB - Institute for Health and Bioeconomy, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa (FCT-NOVA)
Instituto de Tecnologia - Química e
Biológica, Universidade Nova de Lisboa (ITQB-NOVA)
Instituto Gulbenkian de Ciência
|
STAGE
1
|
Medical Devices
|
49,000
|
|
CI23-10184
|
Luminopsins in Parkinson’s disease stimulation
|
Luisa Lopes
|
Instituto de Medicina Molecular
|
Individual
|
N/A
|
STAGE
1
|
Therapeutics
|
50,000
|
|
CI23-10272
|
A versatile and stress-resistant biocatalyst nanoplatform for pathogen detection
|
Mónica Serrano
|
Universidade Nova de Lisboa
|
Individual
|
N/A
|
STAGE
1
|
Diagnostics
|
49,000
|
|
CI23-10330
|
A novel liquid biopsy approach for early breast cancer detection in lactating women
|
Ana Vivancos
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Individual
|
N/A
|
STAGE
1
|
Diagnostics
|
50,000
|
|
CI23-10376
|
Preliminar demonstration and valorization of therapeutic rewiring of (partially) severed spinal cord
|
Maurizio Prato
|
Asociación Centro de Investigación Cooperativa en Biomateriales
|
Individual
|
N/A
|
STAGE
1
|
Medical Devices
|
50,000
|
|
CI23-10380
|
New subset of neutrophils as a biomarker and a therapeutic target for metastatic breast cancer
|
Maria de Guadalupe Gonçalves
|
Universidade Nova de Lisboa
|
Individual
|
N/A
|
STAGE
1
|
Therapeutics
|
49,000(*)
|
|
CI23-10420
|
Targeting microtubule polyglutamylation for cancer therapy
|
Isabelle Vernos
|
Centre de Regulació Genòmica (CRG)
|
Individual
|
N/A
|
STAGE
1
|
Therapeutics
|
50,000
|
|
CI23-10434
|
RACE Plus: AI-driven application to allow pre-hospital diagnosis and management of stroke patients
|
Natalia Pérez de la Ossa
|
Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
|
Individual
|
N/A
|
STAGE
1
|
Digital Health
|
50,000
|
|
CI23-10562
|
Developing a new therapeutic approach to overcome resistance to checkpoint inhibitors
|
Rodrigo Toledo
|
Fundació privada Institut Investigació Oncologica Vall Hebron (VHIO)
|
Individual
|
N/A
|
STAGE
1
|
Therapeutics
|
48,700
|
|
CI23-20154
|
New Biomarker for NAFLD and NASH Development and Progression
|
David Martinez
|
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
|
Individual
|
N/A
|
STAGE
1
|
Diagnostics
|
50,000
|
|
CI23-20369
|
CarboSign7 for pancreatic cancer diagnosis: Biosampling optimization
|
Oscar Pozo
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
Consortium
|
Hospital del Mar - Parc de Salut MAR
|
STAGE
1
|
Diagnostics
|
50,000
|
|
CI23-20043
|
Novel gut-restricted first-in-class therapy for Inflammatory Bowel Disease
|
Isabel Huber
|
Fundació Institut d'Investigació Sanitària Pere Virgili
|
Individual
|
|
STAGE
2
|
Therapeutics
|
150,000
|
|
CI23-20067
|
Novel far-red/NIR-activatable PDT agents for combating hypoxic tumors
|
Vicente Marchán
|
Universitat de Barcelona
|
Individual
|
N/A
|
STAGE
2
|
Therapeutics
|
150,000
|
|
CI23-20148
|
Arteriovenous Fistula for Dialysis: Machine Learning based models for failure and Cardiac events
|
José Ibeas
|
Fundació Institut d'Investigació i Innovació Parc Taulí (I3PT)
|
Individual
|
N/A
|
STAGE
2
|
Digital Health
|
150,000
|
|
CI23-20210
|
BlaDimiR, non-invasive urine-based diagnostic and therapy response predictor for bladder cancer
|
Marta Dueñas
|
Fundación para la Investigación Biomédica del Hospital Universitario 12 de Octubre
|
Individual
|
N/A
|
STAGE
2
|
Diagnostics
|
143,000
|
|
CI23-20216
|
Biohybrid hydrogels as Artificial Tissues against Cancer
|
Judith Guasch
|
Consejo Superior de Investigaciones Científicas (CSIC)
|
Individual
|
N/A
|
STAGE
2
|
Medical Devices
|
150,000
|
|
CI23-20229
|
Humanized Wnt-11 antibodies for cancer therapy: further validation and asset development
|
Robert Kypta
|
Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE
|
Individual
|
N/A
|
STAGE
2
|
Therapeutics
|
150,000
|
|
CI23-20433
|
Microbiome-associated biomarkers for improved anal cancer prevention
|
Sergio Serrano-Villar
|
Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
|
Consortium
|
Instituto de Catálisis y Petroleoquímica (ICP), CSIC Marie Curie, 2 – 28049 Madrid, Spain
|
STAGE
2
|
Diagnostics
|
135,261
|
|
CI23-20487
|
Proof of concept for development of an ATMP based on modified pericytes for glioblastoma treatment
|
Rut Valdor
|
Universidad de Murcia
|
Individual
|
|
STAGE
2
|
Therapeutics
|
150,000
|
|
CI23-20514
|
Duacept, a novel bi-specific fusion protein to prevent transplant rejection
|
Oriol Bestard
|
Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (VHIR)
|
Individual
|
N/A
|
STAGE
2
|
Therapeutics
|
148,500
|
|
CI23-20559
|
DUFIC, a device for in vivo uterine fluid collection
|
Pilar Coy
|
Universidad de Murcia
|
Individual
|
N/A
|
STAGE
2
|
Medical Devices
|
149,500
|
|
CI23-30155
|
Treating Liver Disease with Therapeutic RNA
|
Maria Luz Martinez
|
Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE
|
Individual
|
N/A
|
STAGE
2
|
Therapeutics
|
150,000
|
|
CI23-30260
|
MICROSCREEN_CRC: Microbial biomarker test for early diagnosis of colorectal cancer (MiCRC)
|
Olfat Khannous
|
Fundació Institut de Recerca Biomèdica (IRB Barcelona)
|
Individual
|
N/A
|
STAGE
2
|
Diagnostics
|
150,000
|
|
CI23-30015
|
FIBROKIT: First IVD-based non-invasive monitoring of kidney fibrosis
|
Francesc E. Borras
|
Fundació Institut d’Investigació en Ciencies de la Salut Germans Trias i Pujol (IGTP)
|
Individual
|
N/A
|
STAGE
3
|
Diagnostics
|
300,000
|
|
CI23-30316
|
LCOR mRNA NanoTherapies - A paradigm shift in immunotherapies against cancer
|
Toni Celià-Terrassa
|
Fundació Institut Hospital del Mar d'Investigacions Mèdiques (IMIM)
|
Individual
|
N/A
|
STAGE
3
|
Therapeutics
|
500,000
|
